![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of ABT-450/r and ABT-267 in Treatment-Experienced HCV Subgenotype 1b- and Genotype 2-Infected Japanese Subjects
|
|
|
Reported by Jules Levin
Asian Pacific Association for The Study of the Liver, Brisbane (APASL -2014)
Presenter: Prajakta Badri
14 March 2014
Authors: P Badri, S Dutta, L Rodrigues Jr. ,
RA Vilchez, B Bernstein, R Menon
AbbVie, Global Pharmaceutical R&D, North Chicago, IL, USA
![APASL1.gif](../images/031714/031714-11/APASL1.gif)
![APASL2.gif](../images/031714/031714-11/APASL2.gif)
![APASL3.gif](../images/031714/031714-11/APASL3.gif)
![APASL4.gif](../images/031714/031714-11/APASL4.gif)
![APASL5.gif](../images/031714/031714-11/APASL5.gif)
![APASL6.gif](../images/031714/031714-11/APASL6.gif)
![APASL7.gif](../images/031714/031714-11/APASL7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|